Abstract
At VAM 2010 & 2011, we have reported that preoperative injection of the free-radical scavenger, edaravone (Radicut®, Mitsubishi Tanabe Pharma Co., Japan) prevented reperfusion injury. In this study, we evaluated whether edaravone can reduce reperfusion injury if injected at the start of reperfusion. Male Lewis rats (525 ± 78 g, n = 10) were subjected to reperfusion injury models by clamping the bilateral common femoral arteries for 5 hours followed by de-clamping. Rats were divided into two groups and intraperitoneally injected with edaravone (group edaravone; 9.0 mg / kg, n = 5) or saline (control group; n = 5) at the same time as removing the clamps. Five hours after de-clamping, the muscles of lower extremity were harvested. Tissues were stained with hematoxylin & eosin (HE), in order to count the viable muscle cells. They were also stained with periodic acid-Schiff (PAS), in order to assess the glycogen storage in muscle cells. The density of viable muscle cells in the group edaravone was significantly greater than that of control group (593±60 cells/mm2 vs. 258±31 cells/mm2, P < .01). The mean percentage of PAS-positive area in the edaravone group was also significantly higher than that in control group (30.1 ± 6.9 % vs. 7.3 ± 2.1%, P < .001, Fig, original 200x). Our results suggest that edaravone injected at the start of reperfusion can also reduce muscle injury following leg ischemia in rats, storing a high level of glycogen in viable muscle cells. Therefore, edaravone might be useful in clinical settings following leg ischemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.